Metastatic brain tumor models and drug brain penetration analysis

Abstract Among the adult brain tumors, metastatic brain tumors are the most frequently observed in the United States. The high mortality of metastatic brain tumors is partly due to poor drug accumulation in the brain, accounting for persistent treatment failure. The three critical elements for successful selection of novel drugs for the treatment of metastatic brain tumors are effective drug carriers for blood brain barrier (BBB) penetration, sensitive measurement of drug uptake in the brain, and relevant mouse metastatic brain tumor models. In this chapter, we discuss various animal models for metastatic brain tumor investigation, functions of the BBB, measurement of drug intake in brain and drug carriers for drug BBB penetration and brain accumulation. We believe that with the advancement and improvement of technology, new drugs with high BBB penetration and strong anticancer activity will be more readily available for treatment of human metastatic brain tumors.

• Publication year

  2019

• Venue

  Animal Models in Cancer Drug Discovery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-12-814704-7.00008-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards Improvements for Penetrating the Blood–Brain Barrier—Recent Progress from a Material and Pharmaceutical Perspective

  2018cited by this paper
• Spontaneous development of intratumoral heterogeneity in a transposon‐induced mouse model of glioma

  2018cited by this paper
• Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer

  2017cited by this paper
• Development and Function of the Blood-Brain Barrier in the Context of Metabolic Control

  2017cited by this paper
• The role of the neural niche in brain metastasis

  2017cited by this paper
• Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models

  2017cited by this paper
• Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor

  2017cited by this paper
• Development of a Patient-Derived Xenograft Model Using Brain Tumor Stem Cell Systems to Study Cancer.

  2016cited by this paper
• Athymic nude mice as an experimental model for cancer treatment.

  2016cited by this paper
• Sobetirome prodrug esters with enhanced blood-brain barrier permeability.

  2016cited by this paper
• Magneto-electro-responsive material based on magnetite nanoparticles/polyurethane composites.

  2016cited by this paper
• Albumin Nanoparticles for Brain Delivery: A Comparison of Chemical versus Thermal Methods and in vivo Behavior

  2016cited by this paper
• Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain

  2016cited by this paper
• In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use

  2016cited by this paper
• American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

  2016cited by this paper
• Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.

  2016cited by this paper
• Comparative Analysis of piggyBac, CRISPR/Cas9 and TALEN Mediated BAC Transgenesis in the Zygote for the Generation of Humanized SIRPA Rats

  2016cited by this paper
• Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer

  2016cited by this paper
• Exosomes as drug delivery vehicles for Parkinson's disease therapy.

  2015cited by this paper
• Phosphodiesterase type 5 inhibitor Tadalafil increases Rituximab treatment efficacy in a mouse brain lymphoma model

  2015cited by this paper
• Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio

  2015cited by this paper
• Brain metastasis: clinical characteristics, pathological findings and molecular subtyping for therapeutic implications

  2015cited by this paper
• Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles.

  2015cited by this paper
• Fabrication of flexible and self-standing inorganic-organic three phase magneto-dielectric PVDF based multiferroic nanocomposite films through a small loading of graphene oxide (GO) and Fe3O4 nanoparticles.

  2015cited by this paper
• Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.

  2015cited by this paper
• ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice

  2014cited by this paper
• In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies

  2014cited by this paper
• Therapeutic Efficacy of Aldoxorubicin in an Intracranial Xenograft Mouse Model of Human Glioblastoma

  2014cited by this paper
• Primary Porcine Brain Microvessel Endothelial Cell Isolation and Culture

  2014cited by this paper
• Human Serum Albumin-Based Nanoparticle-Mediated In Vitro Gene Delivery

  2014cited by this paper
• Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.

  2014cited by this paper
• Precarity of place: a complement to the growing precariat literature

  2014cited by this paper
• Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging

  2013cited by this paper
• Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model.

  2013cited by this paper
• Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.

  2013cited by this paper
• Conditional gene expression systems in the transgenic rat brain

  2012cited by this paper
• urface masking shapes the traffic of the neuropeptide Y Y 2 receptor

  2012cited by this paper
• GFAP-Cre-Mediated Transgenic Activation of Bmi1 Results in Pituitary Tumors

  2012cited by this paper
• Brainpeps: the blood–brain barrier peptide database

  2012cited by this paper
• Conditional Astroglial Rictor Overexpression Induces Malignant Glioma in Mice

  2012cited by this paper
• In vivo models of primary brain tumors: pitfalls and perspectives

  2012cited by this paper
• Drug Transport across the Blood–Brain Barrier

  2012cited by this paper
• Modern methods for delivery of drugs across the blood-brain barrier.

  2012cited by this paper
• A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer

  2012cited by this paper
• Exosome-mediated delivery of siRNA in vitro and in vivo

  2012cited by this paper
• In vitro models of the blood-brain barrier.

  2012cited by this paper
• Analytical and biological methods for probing the blood-brain barrier.

  2012cited by this paper
• Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers

  2011cited by this paper
• Characterization and Validation of Cre-Driver Mouse Lines.

  2011cited by this paper
• A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients

  2011cited by this paper
• Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

  2011cited by this paper
• How genetically engineered mouse tumor models provide insights into human cancers.

  2011cited by this paper
• Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model

  2011cited by this paper
• Magnetic resonance imaging-guided microdialysis cannula implantation in a spontaneous high-grade glioma murine model.

  2011cited by this paper
• Glioma models: new GEMMs add "class" with genomic and expression correlations.

  2011cited by this paper
• How to measure drug transport across the blood-brain barrier

  2011cited by this paper
• Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer

  2010cited by this paper
• Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.

  2010cited by this paper
• Modeling metastasis in the mouse.

  2010cited by this paper
• Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.

  2010cited by this paper
• A prediction model for blood-brain barrier permeation and analysis on its parameter biologically

  2009cited by this paper
• Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.

  2009cited by this paper
• A reproducible brain tumour model established from human glioblastoma biopsies

  2009cited by this paper
• Genes that mediate breast cancer metastasis to the brain

  2009cited by this paper
• Remission of Invasive, Cancer Stem-Like Glioblastoma Xenografts Using Lentiviral Vector-Mediated Suicide Gene Therapy

  2009cited by this paper
• Prodrug Approaches for CNS Delivery

  2008cited by this paper
• Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.

  2008cited by this paper
• In vivo MRI of cancer cell fate at the single‐cell level in a mouse model of breast cancer metastasis to the brain

  2006cited by this paper
• Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma

  2006cited by this paper
• Metastasis from human breast cancer cell lines

  2005cited by this paper
• The blood-brain barrier: Bottleneck in brain drug development

  2005cited by this paper
• New positron emission tomography tracer [11C]carvedilol reveals P‐glycoprotein modulation kinetics

  2005cited by this paper
• Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice

  2004cited by this paper
• Extensive Distribution of Liposomes in Rodent Brains and Brain Tumors Following Convection-Enhanced Delivery

  2004cited by this paper
• Pro-Matrix Metalloproteinase-2 Transfection Increases Orthotopic Primary Growth and Experimental Metastasis of MDA-MB-231 Human Breast Cancer Cells in Nude Mice

  2004cited by this paper
• PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.

  2004cited by this paper
• Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.

  2003cited by this paper
• Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting

  2002cited by this paper
• Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors.

  2002cited by this paper
• The seed and soil hypothesis: vascularisation and brain metastases.

  2002cited by this paper
• Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy

  2001cited by this paper
• The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice.

  1998cited by this paper
• Combined Use of Carboxyl-Directed Protein Pegylation and Vector-Mediated Blood-Brain Barrier Drug Delivery System Optimizes Brain Uptake of Brain-Derived Neurotrophic Factor Following Intravenous Administration

  1998cited by this paper
• Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft.

  1997cited by this paper
• Transcriptional induction of the melanocyte-stimulating hormone receptor in brain metastases of murine K-1735 melanoma.

  1995cited by this paper
• Critical factors regulating site-specific brain metastasis of murine melanomas.

  1993cited by this paper
• Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.

  1993cited by this paper
• Macrophage infiltration into experimental brain metastases: occurrence through an intact blood-brain barrier.

  1988cited by this paper
• JB/MS murine melanoma: A new model for studies on the modulation of differentiation and of tumorigenic and metastatic potential

  1988cited by this paper
• Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals.

  1988cited by this paper
• Correlation of frequency of induced mutation and metastatic potential in tumor cell lines from a single mouse mammary tumor.

  1985cited by this paper
• Development of a metastatic brain tumor model in mice.

  1979cited by this paper
• Specificity of arrest, survival, and growth of selected metastatic variant cell lines.

  1978cited by this paper
• Fine-structural changes of reacting glial cells by experimental brain tumours induced transplacentally by N-ethyl-N-nitrosourea in rats.

  1971cited by this paper
• Karyotype analysis of the B16 mouse melanoma with reassessment of the normal mouse idiogram.

  1970cited by this paper
• Erzeugung neurogener Tumoren bei den Nachkommen nach einmaliger Injektion von Äthylnitrosoharnstoff an schwangere Ratten

  1966cited by this paper
• Characteristics

  1895cited by this paper

• No citing papers are available for this paper.